# Invocata

Source: https://onco.cc/companies/invocata/  
OnCo record `invocata` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Invocata is building personalised T-cell receptor therapies, choosing the right TCR for the individual patient at the right time; its site says only that it is coming soon.

## Summary

Invocata describes personalised oncology platforms designed for the individual, moving cancer care towards an N of 1, with T-cell receptor (TCR) therapy as its route: engineering a patient's T cells to carry a receptor that recognises their own tumour. The public site is a placeholder. It is an Even One Ventures portfolio company.

## Fields

- Kind: Company
- Last checked: 2026-09-10
- Tags: startup; evenone-portfolio; oncology
- HQ: United States (head office not published)
- Type: cell-therapy
- Website: https://invocata.bio/

## Sources

- Official website: https://invocata.bio/
- Even One Ventures portfolio: https://evenone.ventures/

## Connected records

- technologies: [TCR-T cell therapy](https://onco.cc/technologies/tcr-t/)
- companies: [Even One Ventures](https://onco.cc/companies/evenone-ventures/)

---
JSON: https://onco.cc/api/v1/entities/invocata.json